GenPath Oncology

Webinar alert on 2/21! Archer, of Integrated DNA Technologies, & speaker Wojciech Swat, PhD, FACMG, Medical Director at GenPath® Oncology will speak on advanced comprehensive genomic panels for myeloid neoplasms. ➡️ bit.ly/3YQWKsI

Attending the 64th #ASH Meeting? Our team would love to connect! Meet us at booth #305 and let’s discuss how GenPath's comprehensive test offerings can support the continuum of care of your patients with #blood disorders.

Are you attending the 64th #ASH Meeting in New Orleans? Connect with our team at booth #305 to discover our cutting edge #NGS portfolio for hematologic malignancies with unmatched turnaround times for results.

Are you planning to attend #AMP2022 in Phoenix, Arizona? Come see us at booth 732 to learn about our cutting edge #NGS panels and new test offerings for chronic lymphocytic leukemia (CLL).

Today is #WorldLungCancerDay – an opportunity to raise awareness about this disease and highlight the risk factors, screening, and treatment options. Learn more about #lungcancer here: bit.ly/2NYoxo8

#UVSafetyMonth brings a time to shine a light on the importance of sun safety and #skincancer prevention. Read about risk factors for skin cancer – like exposure to UV light – sun protection, and more, here: bit.ly/3PDcfQq

Overexposure to the sun can cause irreversible #skin damage such as dark spots and wrinkles, and may also increase the chance of developing #skincancer bit.ly/3RuiB67. #uvsafetyawarenessmonth #uvsafety

Participating in outdoor activities is one of the best parts of summer. While enjoying the warm weather, be sure to protect your skin from the sun by applying sunscreen, wearing protective clothes and hats, sunglasses, etc. Learn more here bit.ly/3bmnEPV #uvsafetymonth

GenPath® Oncology, a specialty division of BioReference Laboratories will be exhibiting at the 2022 #ASCO Annual Meeting. Visit booth 3138 to learn about GenPath’s state-of-the-art #NGS and other testings.

We are delighted to attend the 2022 American Society of Clinical Oncology #ASCO Annual Meeting. Please meet us at booth 3138. We hope to see you there!

GenPath® Oncology, a specialty division of BioReference Laboratories will be exhibiting at the 2022 #ASCO Annual Meeting. Visit booth 3138 to learn about GenPath’s state-of-the-art #NGS and other testings.

We are delighted to attend the 2022 American Society of Clinical Oncology #ASCO Annual Meeting. Please meet us at booth 3138. We hope to see you there!

GenPath® Oncology, a specialty division of BioReference Laboratories will be exhibiting at the 2022 #ASCO Annual Meeting. Visit booth 3138 to learn about GenPath’s state-of-the-art #NGS and other testings.

Smoking causes about 20% of all cancers and about 30% of all cancer deaths in the U.S. bit.ly/3GBqotX. This World No-Tobacco Day, join us in sharing crucial health information about the dangers of smoking and tobacco use bit.ly/38zsVsb #WorldNoTobaccoDay

We are delighted to attend the 2022 American Society of Clinical Oncology #ASCO Annual Meeting. Please meet us at booth 3138. We hope to see you there!

On Memorial Day, let’s pause to remember and honor those who sacrificed their lives to serve our nation. #MemorialDay

A mole that is changing in size, shape, or color, is one of the warning signs of skin cancer. bit.ly/3yI1G61 Regular self-examination of your skin may help identify early signs of skin cancer. Learn how to do a skin self-exam here bit.ly/2ylF7dI

Melanoma is a #skincancer type that develops when melanocytes (the cells that give the skin its tan or brown color) grow out of control. It accounts for 1% of skin cancer but is more dangerous and likely to spread to other body parts. bit.ly/3kY3og4.

Melanoma and other skin cancers can be prevented by avoiding too much exposure to Ultraviolet (UV) rays and protecting your skin from the sun through the use of sunscreens, hats, and sunglasses. Can melanoma be found early? Find out here bit.ly/3k94GUV #MelanomaMonday

GeneDx, Inc. has been acquired by Sema4, allowing BioReference to focus efforts on realizing our goals and continue investments into digitally-enabled, innovative and customized healthcare solutions. Read more here bit.ly/383t5rg